Effects of Lactoflora Administered Nasally: Results of a Primary Study
Authors:
Kabelka Z.†; D. Kolešková 1; Z. Krylová 1; A. Šalaková 2; V. Dráb 2; O. Nyč 3; V. Klemensová 3
Authors place of work:
ORL klinika 2. LF UK a FN Motol, Praha
1; Výzkumný ústav mlékárenský, s. r. o., Praha
2; Ústav lékařské mikrobiologie 2. LF UK a FN Motol, Praha
3
Published in the journal:
Otorinolaryngol Foniatr, 63, 2014, No. 3, pp. 182-186.
Category:
Original Article
Summary
Probiotics are topic of interest of clinical as well industry researchers, because of their biological and economical potential. Nasal application in the world letters was not published yet. Safety L. acidophilus CCD151 a L. helveticus CCGM 98 mixture was tested in adults and than used in children in the initial phase of a nasal, nasopharyngeal infection. In the set of 76 children using lactoflora solution intranasally in 8.1 % was necessary use antibiotics in the further treatment, in the control set of 31 children in 22 %. There were no serious adverse reactions.
Keywords:
probiotics, Lactobacillus acidophilus, rhinitis, nasopharyngitis, intranasal administration
Zdroje
1. Alvarez-Olmos, M. I.: Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis., 32, 2001, s. 1567-1576.
2. Ataie-Jafari, A., Larijani, B., Alavi Majd, H., Tahbaz, F.: Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab., 54, 2009, s. 22-27.
3.Cannon, J. P., Lee, T. A., Bolanos, J. T., Danziger, L. H.: Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis., 24, 2005, s. 31-40.
4. Chitapanarux, I., Chitapanarus, T., Traisathit, P. et al.: Randomized controlled trial of live lactobacillus acidophilu plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat. Oncol., 5, 2010, s. 31.
5. Cunninghem-Rundles, S., Ahrne, S., Bengmark, S., Johann-Liang, R., Marshall, F., Metakis, L., Califano, C., Dunn, A. M., Grassey, C., Hinds, G., Cervia, J.: Probiotics and immune response. Am. J. Gastroenterol., 95, 2000, s. S22-S25.
6. Dongarrà, M. L., Rizzello, V., Muccio, L., Fries, W., Cascio, A., Bonaccorsi, I., Ferlazzo, G.: Mucosal immunology and probiotics. Abstrakt Curr. Allergy Asthma Rep., 13, 2013, s. 19-26.
7. Ellis, C. L., Rutledge, J. C., Underwood, M. A.: Intestinal microbiota and blue baby syndrome. Gut Microbes., 1, 2010, s. 359-366.
8. Ewaschuk, J. B., Dieleman, L. A.: Probiotics and prebiotics in chronic inflammatory bowel diseases. World J. Gastroenterol., 12, 2006, s. 5941-5950.
9. Fedorak, R. N., Madsen, K. L.: Probiotics and the management of inflammatory bowel disease. Inflamm. Bowel Dis., 10, 2004, s. 286-299.
10. Friedrich, M. J.: A bit of culture for children: probiotics may improve health and fight disease. JAMA, 284, 2000, s. 1365-1366.
11. Gao, X. W., Mubasher, M., Fang, C. Y., Reifer, C., Miller, L. E.:Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am. J. Gastroenterol., 105, 2010, s. 1636-1641.
12. Gill, H. S., Rutherford, K. J., Cross, M. L.: Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J. Clin. Immunol., 21, 2001, s. 264-271.
13. Gill, H. S., Rutherford, K. J., Cross, M. L., Gopal, P. K.: Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr., 74, 2001, s. 833-839.
14. Gionchetti, P., Rizzello, F., Ventura, A., Campieri, M.: Probiotics in infective diarrhea and inflammatory bowel diseases [Review]. J. Gastroenterol. Hepatol., 15, 2000, s. 489-493.
15. Hatakka, K., Savilahti, E., Pönkä, A., Meurman, J. H., Poussa, T., Näse, L., Saxelin, M., Korpela, R.: Effect of long term consumption of probiotic milk on infections in children attending day care centers: double-blind, randomized trial. BMJ, 322, 2001, s. 1327.
16. Hsieh, P. S., Tsai, Y. C., Chen, Y. C., Teh, S. F., Ou, C. M., King, V. A.: Eradication of helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter., 17, 2012, s. 466-477.
17. Chitapanarux, I., Chitapanarus, T., Traisathit, P., Kudumpee, S., Tharavichitkul, E., Lorvidhaya, V.: Randomized controlled trial of live lactobacillus acidophilu plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat. Oncol., 5, 2010, s. 31.
18. Ishida, Y., Nakamura, F., Kanzato, H., Sawada, D., Yamamoto, N., Kagata, H., Oh-Ida, M., Takeuchi, H., Fuji-wara, S. : Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnik. Biochem., 69, 2005, s. 1652-1660.
19. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., Isolauri, E.: Probiotics in primary prevention of atopic disease: a randomized placebo controlled trial. Lancet., 357, 2001, s. 1076-1079.
20. Kopp, M. V., Salfeld, P.: Probiotics and prevention of allergic disease. Review. Curr. Opin. Clin. Nutr. Metab. Care, 12, 2009, s. 298-303.
21. Leyer, G. J., Li, S., Mubasher, M. E., Reifer, C., Ouwe-hand, A. C.: Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics., 124, 2009, s. 172-179
22. Marteau, P. R., de Vrese, M., Cellier, C. J., Schrezenmeir, J.: Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr., 73, 2001, s. 430S-436S.
23. Martinez, R. C., Franceschini, S. A., Patta, M. C., Quintana, S. M., Candido, R. C., Ferreira, J. C., De Martinis, E. C., Reid, G.: Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol., 48, 2009, s. 269-274.
24. Mayo clinic: Acidophilus (Lactobacillus acidophilus): http://www.mayoclinic.com/health/lactobacillus/NS_patient-acidophilus
25. McFarland, L. V.: Meta-analysis of probiotics for the prevention of traveler‘s diarrhea. Travel Med. Infect. Dis., 5, 2007, s. 97-105.
26. Meydani, S. N., Ha, W. K.: Immunologic effects of yogurt. Am. J. Clin. Nutr., 71, 2000, s. 861-872.
27. Mukerji, S. S., Pynnonen, M. A., Kim, H. M., Singer, A., Tabor, M., Terrell, J. E.: Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial. Otolaryngol Head Neck Surg., 140, 2009, s. 202-208.
28. Rammelsberg, M., Radler, F.: Antibacterial polypeptides of Lactobacillus species. Journal of Applied Microbiology, 69, 1990, s. 177-184.
29. Reid, G.: Probiotic agents to protect the urogenital tract against infection. [Review]. Am. J. Clin. Nutr., 73, 2001, s. 437S-443S.
30. Rohde, C. L., Bartolini, V., Jones, N.: The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Nutr. Clin. Pract., 24, 2009, s. 33-40.
31. Sheih, Y. H.: Systemic immunity-enhancing effects in health subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr., 20, 2001, s. 149-156.
32. Singh, V., Raheja, G., Borthakur, A., Kumar, A., Gill, R. K., Alakkam, A., Malakooti, J., Dudeja, P. K.: Lactobacillus acidophilus Upregulates Intestinal NHE3 Expression and Function. Am. J. Physiol. Gastrointest. Liver Physiol., 15, 2012, s. 1393-1401.
33. Shakirova, L., Grube, M., Gavare, M., Auzina, L., Zikma-nis, P.: Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 cell surface hydrophobicity and survival of the cells under adverse environmental conditions. J. Ind.Microbiol. Biotechnol., 40, 2013, s. 85-93.
34. Skopińska, E., Lachowicz, D., Wultańska, D., Pawłow-ska, J., Jedrzejewska, A., Obuch-Woszczatyński, P., Pituch, H.:Assessment of antagonistic activity in vitro Lactobacillus spp. strains againts Clostridum difficile strains isolated from gastrointestinal tract of patients hospitalized in three hospitals in region Mazovia. Abstrakt Med. Dosw. Mikrobiol., 64, 2012, s. 109-114.
35. Sugumari, E., Piranitha, J., Thamaraiselvan, M.: Bugs that debugs: Probiotics. J. Pharm. Bioallied. Sci., 4, 2012, s. S319–S322.
36. University of Maryland Medical Systemryland Medical System: Lactobacillus acidophilus http://www.umm.edu/altmed/articles/lactobacillus-acidophilus-000310.htm#ixzz2AOrcFMJZ, I, 1-8.
Štítky
Audiology Paediatric ENT ENT (Otorhinolaryngology)Článok vyšiel v časopise
Otorhinolaryngology and Phoniatrics
2014 Číslo 3
Najčítanejšie v tomto čísle
- Therapy of Percentual Hearing Loss by Rheohemapheresis – First Experience
- Facial (Craniofacial) Epitheses
- Effects of Lactoflora Administered Nasally: Results of a Primary Study
- Importance of Vascular Endothelial Growth Factor (VEGF) for Metastatic Dissemination of Adenoid Cystic Carcinoma of Salivary Glands